{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:26:35Z","timestamp":1787235995829,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"vor","delay-in-days":2832,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.anpedi.2010.10.004","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T04:42:51Z","timestamp":1294375371000},"page":"132.e1-132.e19","source":"Crossref","is-referenced-by-count":10,"title":["Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2011"],"prefix":"10.1016","volume":"74","author":[{"given":"J.","family":"Mar\u00e8s Berm\u00fadez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"van Esso Arbolave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Moreno-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ar\u00edstegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barrio Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez-Hachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2010.10.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.anpedi.2010.02.009","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2010","volume":"72","author":"Mar\u00e8s Berm\u00fadez","year":"2010","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0010","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years \u2013 United States, 2010. MMWR 2010;58:51\u20132."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0015","first-page":"203","article-title":"Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children","volume":"4","author":"Meyer","year":"2008","journal-title":"Standard pediatric versus a reduced-antigen content formulation. Hum Vaccin."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0020","first-page":"1008","article-title":"Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine","volume":"58","year":"2009","journal-title":"MMWR."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0025","unstructured":"Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP); Part 1: Immunization of infants, children, and adolescents. MMWR 2005;54(No.RR-16):1\u201333."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0030","unstructured":"Menveo\u00ae (Novartis). Ficha t\u00e9cnica. Disponible en: www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/001095\/WC500090147.pdf. Acceso 26 de octubre 2010"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infec Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0050","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pediatric pneumococcal serotypes in 4 European countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0060","doi-asserted-by":"crossref","unstructured":"Fenoll A, Aguilar L, Vicioso MD, Gim\u00e9nez NJ, Robledo O, Granizo JJ, et al. Serotype distribution of Spanish Streptococcus pneumoniae isolates from pleural fluid (1997\u20132008). 6th Congress of the World Society for Pediatric Infectious Diseases (WSPID). Buenos Aires, Argentina, 18\u201322 Noviembre 2009.","DOI":"10.1128\/AAC.00217-10"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0065","unstructured":"Fenoll A, Aguilar L, Vicioso MD, Gim\u00e9nez MJ, Robledo O, Granizo JJ, et al. Serotype distribution and susceptibility of Spanish Streptococcus pneumoniae isolates from middle ear fluid in 2000's. 28th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Nice, France, 4-8 Mayo 2010. Abstract 350."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Mu\u00f1oz-Almagro","year":"2009","journal-title":"J Infect."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0075","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Castillo F, Hern\u00e1ndez San Pelayo T, et al. Invasive Streptococcus pneumoniae serotype distribution among hospitalized pediatric population in Madrid (May 2007-April 2008). 27th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Brussels, Belgium, 9\u201313 Junio 2009. Abstract 742."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0085","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":"Pediatric parapneumonic empiema","volume":"14","author":"Obando","year":"2008","journal-title":"Spain. Emerg Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0090","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.332.7553.1333","article-title":"Empyema is still in UK children","volume":"332","author":"Spencer","year":"2006","journal-title":"BMJ."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Mu\u00f1oz-Almagro","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0100","article-title":"Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in the current decade in Spain","author":"Fenoll","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0105","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe fatal outcome","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0115","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin In fect Dis."},{"issue":"Suppl 3","key":"10.1016\/j.anpedi.2010.10.004_bib0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"Dagan","year":"2009","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0135","unstructured":"Web de la Agencia Europea de Medicamentos. Ficha t\u00e9cnica de Synflorix. Disponible en: http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/synflorix\/emea-combined-h973es.pdf. Acceso 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0140","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0145","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0150","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0155","unstructured":"Web de la Agencia Europea de Medicamentos. Ficha t\u00e9cnica de Prevenar 13. Disponible en: http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/Prevenar13\/emea-combined-h1104es.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0160","unstructured":"D\u00edez-Domingo J, Gurtman A, Bernaola E, Gim\u00e9nez-S\u00e1nchez F, Martin\u00f3n-Torres F, Pineda-Solas V, et al. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy infants receiving routine vaccinations in Spain. 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID). Brussels, Belgium. 9-13 Junio 2009. Abstract 908."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1586\/erv.09.68","article-title":"Current knoledge regarding the investigational 13-valent pneumococcal conjugate vaccine","volume":"8","author":"Dinleyici","year":"2009","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0170","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.vaccine.2009.04.021","article-title":"Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines","volume":"27","author":"Rodgers","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0175","series-title":"Pneumococcal vaccines. The impact of conjugate vaccines","first-page":"339","article-title":"Establishing immune correlates of protection","author":"Kohberger","year":"2008"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of anti-pneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomized double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet."},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2010.10.004_bib0190","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.vaccine.2008.05.033","article-title":"Serotypes and pathogens in paediatric pneumonia","volume":"26","author":"Hausdorff","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0195","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pav\u00eda","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0205","unstructured":"Hughes JY, Snape MD, Klinger CL, Daniels E, Layton H, John TM, et al. Immunogenicity of booster doses of 13-valent pneumococcal conjugate and Hib\/MenC vaccines given at 12 months of age in the UK. 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID). Brussels, Belgium, 9\u201313 Junio 2009."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0210","unstructured":"Actualizaci\u00f3n en vacunaci\u00f3n antineumoc\u00f3cica. Recomendaciones del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Disponible en: http:\/\/www.vacunasaep.org\/recomendaciones_vnc_2010.htm. Acceso 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0215","unstructured":"Advisory Committee on Immunization Practices (ACIP) Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59:258\u201361. Disponible en: http:\/\/www.cdc.gov\/mmwr\/PDF\/wk\/mm5909.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0220","unstructured":"Haut Conseil de la sant\u00e9 publique. Relatif \u00e0 la vaccination par le vaccin pneumococcique conjugu\u00e9 13-valent. Avis produit par la Commission sp\u00e9cialis\u00e9e Maladies transmissibles, sur proposition du Comit\u00e9 technique des vaccinations. 11 d\u00e9cembre 2009. P\u00e1gs. 1\u20139. Disponible en: http:\/\/www.hcsp.fr\/explore.cgi\/hcspa20091211_vaccpne13valent.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0225","unstructured":"Department of Health. Changes to the Childhood Pneumococcal Conjugate Vaccine. Gateway reference: 13414. Disponible en: http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_111300.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0230","unstructured":"Informe del Comit\u00e9 de Vacunas de la Comunidad de Madrid sobre la transici\u00f3n de la vacunaci\u00f3n antineumoc\u00f3cica infantil. Abril 2010. Disponible en: http:\/\/www.madrid.org\/cs\/Satellite?c=PTSA_Multimedia_FA&cid=1142592655509&pagename=PortalSalud\/PTSA_Multimedia_FA\/PTSA_documentoWebeditpro. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0235","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/INF.0b013e3181bbf2a0","article-title":"Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella","volume":"29","author":"Shah","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0245","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/522146","article-title":"Epidemiology of varicella hospitalizations in the United States, 1995-2005","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0255","unstructured":"Comit\u00e9 Asesor de Vacunas de la Comunidad de Madrid. Servicio Madrile\u00f1o de Salud. Informe sobre varicela en la Comunidad de Madrid, 2010. Disponible en: http:\/\/www.madrid.org. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0260","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0265","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayer","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0270","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella vaccine over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0275","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons. Clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev."},{"issue":"RR-4","key":"10.1016\/j.anpedi.2010.10.004_bib0290","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0295","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1086\/522130","article-title":"Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine","volume":"197","author":"Watson","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0300","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0305","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/INF.0b013e3181967bee","article-title":"Rotavirus overview","volume":"28","author":"Bernstein","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0310","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00431-007-0550-8","article-title":"Gastroenteritis by rotavirus in Spanish children. Analysis of the disease burden","volume":"167","author":"Luquero","year":"2008","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0315","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1542\/peds.2008-2088","article-title":"Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among european children younger than 5 years of age","volume":"123","author":"Forster","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0320","unstructured":"Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2009; 58(RR-2):1\u201325."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0325","unstructured":"Centers for Disease Control and Prevention. Reduction in rotavirus after vaccine introduction \u2014 United States, 2000-2009. MMWR. 2009; 58:1146\u20139."},{"issue":"Supl 2","key":"10.1016\/j.anpedi.2010.10.004_bib0330","first-page":"1","article-title":"Recomendaciones basadas en la evidencia de la Sociedad Europea de Enfermedades Infecciosas Pedi\u00e1tricas y la Sociedad Europea de Gastroenterolog\u00eda. Hepatolog\u00eda y Nutrici\u00f3n pedi\u00e1trica para la vacunaci\u00f3n frente al rotavirus en Europa","volume":"46","author":"Vesikari","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr (Ed. Esp)."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0335","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/1471-2458-10-469","article-title":"Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain","volume":"10","author":"Diez-Domingo","year":"2010","journal-title":"BMC Public Health."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0340","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00431-007-0466-3","article-title":"An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain","volume":"167","author":"Martin\u00f3n","year":"2008","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0345","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1016\/j.vaccine.2010.08.060","article-title":"An update to \u201cThe cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe\u201d","volume":"28","author":"Jit","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0350","unstructured":"World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84:533\u20138."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0355","unstructured":"Calendario de Vacunaciones recomendado (2007). Consejo Interterritorial del Sistema Nacional de Salud. Disponible en: http:\/\/www.msps.es\/ciudadanos\/proteccionSalud\/infancia\/vacunaciones\/programa\/vacunaciones.htm. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0360","unstructured":"Pach\u00f3n I, Mart\u00ednez MV, Su\u00e1rez B, S\u00e1nchez-Fouquier A, Salmer\u00f3n F, Soler M, et al. Situaci\u00f3n epidemiol\u00f3gica de la gastroenteritis producida por rotavirus. Recomendaciones de la vacunaci\u00f3n frente al rotavirus. Documento enviado a la Ponencia de Programa y registro de vacunaciones, Junio 2006. Madrid: Ministerio de Sanidad y Consumo."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0365","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Eng J Med."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0375","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/INF.0b013e3181907177","article-title":"Live attenuated human rotavirus vaccine. RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials","volume":"28","author":"De Vos","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Eng J Med."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0385","unstructured":"Ome\u00f1aca F, Sarlangue J, Wysocki J, Nogueira M, Suryakiran PV, Smolenov IV, et al. Immunogenicity of a rotavirus vaccine (Rotarix\u00ae) in European pre-term infants with different gestational age. 27th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Brussels, Belgium, 9\u201313 Junio 2009. Abstract 645."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0390","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","article-title":"Safety and efficacy of pentavalent humans-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants","volume":"26","author":"Goveia","year":"2007","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0395","unstructured":"Rotavirus vaccination \u2013 WHO does not recommend any change to use of Rotarix vaccine. Disponible en: http:\/\/www.who.int\/immunization\/newsroom\/news_rotavirus_vaccine_use\/en\/index.html. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0400","unstructured":"FDA Revises Recommendations for rotavirus vaccines. Disponible en: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm212149.htm. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0405","unstructured":"European Medicines Agency confirms positive benefit-risk balance of Rotarix. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/07\/news_detail_001059.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0410","unstructured":"European Medicines Agency confirms positive benefit-risk balance of RotaTeq. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/09\/news_detail_001121.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true. Acceso el 26 de octubre 2010"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0415","unstructured":"Nota para profesionales sanitarios. Detecci\u00f3n de ADN de circovirus porcino tipo I y 2 (PCV-1 y PCV-2) en la vacuna frente a rotavirus RotaTeq\u00ae. Disponible en: http:\/\/www.aemps.es\/actividad\/alertas\/usoHumano\/calidad\/2010\/NI_CIRCOVIRUS_rotateq_junio10.htm. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0420","unstructured":"Nota para profesionales sanitarios. Actualizaci\u00f3n de la informaci\u00f3n sobre la detecci\u00f3n de ADN de circovirus porcino (PCV-1) en la vacuna frente a rotavirus Rotarix\u00ae. Disponible en: http:\/\/www.aemps.es\/actividad\/alertas\/usoHumano\/calidad\/2010\/NI_CIRCOVIRUS_22julio10.htm. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0425","unstructured":"Detecci\u00f3n de ADN de circovirus porcino en las vacunas frente rotavirus: Rotarix\u00ae y RotaTeq\u00ae. Documento de consenso de las sociedades cient\u00edficas AEP, AEV, SEIP y SEGHNP. Disponible en: http:\/\/www.vacunasaep.org\/noticias\/rotavirus_consenso_jun2010.htm. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0430","unstructured":"European Medicines Agency. European Medicines Agency confirms positive benefit-risk balance of Rotarix. Press release of 22\/07\/2010. Disponible en: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2010\/07\/WC500094972.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0435","unstructured":"European Medicines Agency. European Medicines Agency confirms positive benefit-risk balance of RotaTeq. Press release of 23\/09\/2010. Disponible en: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2010\/09\/WC500097000.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0440","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0445","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0450","unstructured":"Cervarix, GlaxoSmitKline. Ficha t\u00e9cnica. Actualizaci\u00f3n 8\/08\/2010. Disponible en: http:\/\/www.ema.europa.eu\/. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0455","unstructured":"Gardasil, Sanofi Pasteur MSD. Ficha t\u00e9cnica. Actualizaci\u00f3n 14\/09\/2010. Disponible en: http:\/\/www.ema.europa.eu\/. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0460","unstructured":"Romanowski B, on behalf of the PATRICIA study group. Efficacy of the HPV-16\/18-adjunvanted vaccine against non-vaccine oncogenic HPV types: end-of-study results. 26th International Papillomavirus Conference. Montreal, Canada, 3\u20138 Julio 2010. Abstract 517."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0465","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/j.vaccine.2010.07.007","article-title":"Sustained efficacy and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women","volume":"28","author":"De Carvalho","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0470","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0475","unstructured":"Moscicki AB, Wheeler CM, Romanowski B, Hedrick J, Gall S, Ferris D, et al. Anamnestic response elicited by a fourth dose of the HPV-16\/18-adjuvated vaccine in young women. Eurogin. M\u00f3naco, 17\u201320 Febrero 2010. Abstract SS 11\u20136."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0480","unstructured":"World Health Organization. Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 june 2009. Wkly Epidemiol Rec. 2009;84:325\u201332."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0485","doi-asserted-by":"crossref","unstructured":"Giuliano AR, Anic G, Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol. En prensa 2010.","DOI":"10.1016\/j.ygyno.2010.01.026"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0490","unstructured":"Centers for Diseases Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:630\u20132."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0495","unstructured":"Centers for Diseases Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:626\u20139."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0500","unstructured":"Recomendaciones del Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Vacunaci\u00f3n en la infancia y adolescencia frente a la gripe estacional. Recomendaciones para la campa\u00f1a 2010-2011. Disponible en: http:\/\/www.vacunasaep.org\/gripe_2010_2011.htm (\u00faltimo acceso: 26 octubre 2010)."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0505","unstructured":"Centers for Disease Control and Prevention. Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Early Release. 2010;59:1\u201362."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0510","unstructured":"World Health Organization (WHO). Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Disponible en: http:\/\/www.who.int\/csr\/disease\/influenza\/recommendations2010_11north\/en\/index.html. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0515","unstructured":"World Health Organization (WHO). WHO recommendations for the post-pandemic period. Disponible en: http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/briefing_20100810\/en\/index.html. Acceso el 26 octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0520","unstructured":"Centers for Disease Control and Prevention. Catch-up Immunization schedule for persons aged 4 months through 18 years who start late or who are more than 1 month behind. Disponible en: http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/child\/2010\/10_catchup-schedule-pr.pdf. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0525","unstructured":"The Australian Immunisation Handbook, 9th Edition, 2008. Catch-up - updated July 2009. Disponible en: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/handbook-catchup. Acceso el 26 de octubre 2010."},{"key":"10.1016\/j.anpedi.2010.10.004_bib0530","series-title":"Vacunas para enfermer\u00eda pedi\u00e1trica de atenci\u00f3n primaria","author":"van Esso","year":"2009"},{"key":"10.1016\/j.anpedi.2010.10.004_bib0535","series-title":"Vacunas en el ni\u00f1o. De la teor\u00eda a la pr\u00e1ctica","first-page":"808","article-title":"Ni\u00f1os no vacunados: pautas aceleradas","author":"Corretger","year":"2006"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310004935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310004935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T13:24:30Z","timestamp":1559913870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403310004935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1695403310004935"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2010.10.004","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}